7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
pmid:25240503 | ||||
pmid:25236333 | ||||
pmid:27328677 | ||||
pmid:27318268 | ||||
pmid:27072583 | ||||
pmid:27028343 | ||||
pmid:25016365 | ||||
pmid:25013993 | ||||
pmid:26942563 | ||||
pmid:26936893 | ||||
pmid:24757095 | ||||
pmid:24756971 | ||||
pmid:26648171 | ||||
pmid:26647458 | ||||
pmid:24346335 | ||||
pmid:24337955 | ||||
pmid:26412665 | ||||
pmid:26398902 | ||||
pmid:23104956 | ||||
pmid:22878484 | ||||
pmid:26133738 | ||||
pmid:26131575 | ||||
pmid:25920618 | ||||
pmid:25912212 | ||||
pmid:28363435 | ||||
pmid:28320782 | ||||
pmid:25684548 | ||||
pmid:27925188 | ||||
pmid:25461399 | ||||
pmid:25460576 | ||||
pmid:27729453 | ||||
pmid:27720655 | ||||
pmid:28450653 | ||||
pmid:28429221 | ||||
Wang Y et al. | Puerarin concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production in human osteoblastic MG-63 cells. | Phytomedicine | pmid:24854571 | |
pmid:12354528 | ||||
pmid: | ||||
Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
Hofbauer LC and Heufelder AE | Osteoprotegerin: a novel local player in bone metabolism. | 1997 | Eur. J. Endocrinol. | pmid:9368500 |
Simonet WS et al. | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. | 1997 | Cell | pmid:9108485 |
Hofbauer LC et al. | Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9784422 |
Matsuzaki K et al. | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9600092 |
Takai H et al. | Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. | 1998 | J. Biol. Chem. | pmid:9765225 |
Bucay N et al. | osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. | 1998 | Genes Dev. | pmid:9573043 |
Yamaguchi K et al. | Characterization of structural domains of human osteoclastogenesis inhibitory factor. | 1998 | J. Biol. Chem. | pmid:9478964 |
Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
Schinke T et al. | Molecular determinants of arterial calcification. | 1998 | Ann. Med. | pmid:9920355 |
Akatsu T et al. | Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9753612 |
Hakeda Y et al. | Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. | 1998 | Biochem. Biophys. Res. Commun. | pmid:9790989 |
Horwood NJ et al. | Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. | 1998 | Endocrinology | pmid:9794488 |